Skip to Content

4214 2.5 (Onglyza saxagliptin 2.5 mg)

Generic Name: saxagliptin

Pill with imprint 4214 2.5 is Yellow, Round and has been identified as Onglyza saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.

Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 4214 2.5

Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5 Front
Onglyza saxagliptin 2.5 mg 4214 2.5 Back
Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5


Generic Name:
4214 2.5
saxagliptin 2.5 mg
8.00 mm
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00310-6100 AstraZeneca

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.